1
IMPORTANT
Before using the BLE Smart Blood Glucose Monitoring System for the
first time, read all instructions for use and this User Manual. Consult your
Healthcare Professional to manage your diabetes daily with the BLE Smart
Blood Glucose Monitoring System.
OUR COMMITMENT TO YOU
We understand that self-testing your blood sugar levels provides a way for
you to control your diabetes. As a result, the BLE Smart Blood Glucose
Monitoring System was developed to help you manage your diabetes by the
most comfortable and convenient way possible. Our goal at Entra Health is
to provide you with the best quality products and superior customer service.
If you have any questions or comments, please visit our website at
www.entrahealth.com.
Please contact Customer Support by telephone at +1-877-458-2646 (USA) or
+1-619-684-6232 (International) or by email: [email protected]
INDICATIONS FOR USE
The BLE Smart Blood Glucose Monitoring System (“BLE Smart”) is
comprised of the BLE Smart Meter (with Bluetooth upload capability), BLE
Smart Control Solution, BLE Smart Test Strips and reusable Lancing Device.
The system is intended for the quantitative measurement of glucose (sugar)
in fresh capillary whole blood. Fresh capillary whole blood samples may be
drawn from the fingertips, ventral palm, dorsal hand, upper arm, forearm, calf
and/or thigh. Alternative site testing should be done during steady–state times
(when glucose is not changing rapidly).
BLE Smart Blood Glucose Monitoring System is intended to be used by a
single patient and should not be shared with others.
BLE Smart Blood Glucose Monitoring System is intended for testing outside
the body (in vitro diagnostic use) by people with diabetes at home as an aid
to monitor the effectiveness of diabetes control. It should not be used for the
diagnosis of or screening of diabetes or used on neonates.
BLE Smart Control Solution is for use with the BLE Smart Meter and BLE
Smart Test Strips only. Control solution is used to confirm the meter and test
strips are working together properly.
WARNINGS AND SAFETY INSTRUCTIONS
The Centers for Disease Control and Prevention (CDC) and the US Food and
Drug Administration (FDA) have become increasingly concerned about the
risks for transmitting hepatitis B virus (HBV) and other blood borne pathogens
from shared use of fingerstick (lancing) devices and blood glucose meters.